Table 2.

the cytotoxicity of cisplatin, in A2780/RCIS, multidrug-resistant ovarian carcinoma cells (MRP2-overexpressing ovarian carcinoma cell line) alone or in the presence of compounds

Compound	A2780/RCIS IC50a (μM)	Compound	A2780/RCIS IC50a (μM)
Cis +4a	53.62±3.45	Cis +6a	64.55±1.7
Cis +4b	63.21±2.96	Cis +6b	62.84±2.1
Cis +4c	37.34±3.87	Cis +6c	56.27±3.8
Cis +4d	52.67±4.36	Cis +6d	35.54±0.9
Cis +5a	45.23±4.12	Cis +7a	48.06±0.51
Cis +5b	48.34±3.35	Cis +7b	25.17±1.6
Cis +5c	28.56±5.34	Cis +7c	ND
Cis +5d	54.34±3.95	Cis +7d	14.88±1.1
Cisplatin	57.67±4.61